🔒
Price chart and 15 days of daily prices
Candlestick chart with moving averages, Bollinger bands and MACD.
Register free to view.
Security Profile
- Security Type
- Common Stock
- CUSIP
- 57667K109 (prev. 691828404 )
- Market Cap
- Micro Cap · $18 Million
- Previous Symbol
- MATN (changed 6/3/2021)
- Previous Name
- Mateon Therapeutics, Inc.
Business: Oncotelic Therapeutics, Inc. is a biopharmaceutical company seeking to realize the full potential of vascular targeted therapy (VTT) in oncology. VTT includes vascular disrupting agents (VDAs) such as the investigational drugs that Mateon is developing, and anti-angiogenic agents (AAs), a number of which are FDA-approved and widely used in cancer treatment. These two approaches have distinct yet complementary mechanisms of action.
Notes: December 28, 2012, Stock Split terms:1 for 12._________February 23, 2011, Split terms:1 for 20
Company Contact
- CEO
- Vuong Trieu
- CFO
- Amit Shah
- Headquarters
- 701 Gateway Blvd. Suite 210, South San Francisco, CA 94080
- Phone
- 650-635-7000
- Fax
- 650-635-7001
- Investor Relations
- 650-635-7000